Fig. 1From: A study of glycemic perturbations following two doses of COVID-19 vaccination for patients with diabetes: the impacts of vaccine type and anti-diabetes drugsPercentage of subjects with unfavorable change in each biochemical parameter among participants following COVID-19 vaccinationFigure legend: Moderna and BNT groups had around 60% of patients with elevated HbA1c following two doses of COVID-19 vaccination, while the ChAd group had only 49%Back to article page